We are live on ! Find out more
BLAM

Bourne Lent Asset Management Portfolio holdings

AUM $289M
1-Year Est. Return 30.86%
This Fund
S&P 500
This Quarter Est. Return
+3.03%
1 Year Est. Return
+30.86%
3 Year Est. Return
+76.09%
5 Year Est. Return
+95.46%
10 Year Est. Return
+670.42%
AUM
$248M
AUM Growth
+$1.58M
Cap. Flow
+$579K
Cap. Flow %
0.23%
Top 10 Hldgs %
73.44%
Holding
64
New
4
Increased
10
Reduced
10
Closed
1

Top Buys

Rank Stock Value
1
PACB icon
Pacific Biosciences
PACB
+$364K
2
IBM icon
IBM
IBM
+$210K
3
ADP icon
Automatic Data Processing
ADP
+$208K
4
EME icon
Emcor
EME
+$198K
5
CAT icon
Caterpillar
CAT
+$198K

Top Sells

Rank Stock Value
1
NVTA
Invitae Corporation
NVTA
+$360K
2
BMY icon
Bristol-Myers Squibb
BMY
+$291K
3
PFE icon
Pfizer
PFE
+$111K
4
BKNG icon
Booking.com
BKNG
+$107K
5
GOOG icon
Alphabet (Google) Class C
GOOG
+$26.4K

Sector Composition

Rank Sector Weight
1 Technology 44.62%
2 Healthcare 22.29%
3 Communication Services 15.01%
4 Industrials 7.44%
5 Consumer Discretionary 3.89%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
LHX icon
26
L3Harris
LHX
$53.4B
$1.51M 0.61%
7,090
– –
NVDA icon
27
NVIDIA
NVDA
$5.42T
$1.4M 0.56%
15,440
– –
TSLA icon
28
Tesla
TSLA
$1.3T
$1.38M 0.56%
7,875
– –
BSX icon
29
Boston Scientific
BSX
$71.5B
$1.22M 0.49%
17,769
– –
TROW icon
30
T. Rowe Price
TROW
$24.3B
$1.08M 0.44%
8,867
– –
LOW icon
31
Lowe's Companies
LOW
$125B
$892K 0.36%
3,500
– –
PEG icon
32
Public Service Enterprise Group
PEG
$37.7B
$810K 0.33%
12,122
– –
T icon
33
AT&T
T
$163B
$728K 0.29%
41,341
+100
+0.2% +$1.71K
MRK icon
34
Merck
MRK
$318B
$721K 0.29%
5,467
– –
MCHP icon
35
Microchip Technology
MCHP
$46B
$693K 0.28%
7,720
– –
PEP icon
36
PepsiCo
PEP
$190B
$634K 0.26%
3,625
– –
PFE icon
37
Pfizer
PFE
$153B
$605K 0.24%
21,805
-4,000
-16% -$111K
INTU icon
38
Intuit
INTU
$89B
$523K 0.21%
805
– –
HD icon
39
Home Depot
HD
$355B
$514K 0.21%
1,340
– –
W icon
40
Wayfair
W
$14.6B
$491K 0.2%
7,229
– –
GLD icon
41
SPDR Gold Trust
GLD
$141B
$489K 0.2%
2,375
– –
CNP icon
42
CenterPoint Energy
CNP
$26.8B
$478K 0.19%
16,766
– –
INTC icon
43
Intel
INTC
$513B
$474K 0.19%
10,720
-170
-2% -$7.58K
EOG icon
44
EOG Resources
EOG
$70.7B
$416K 0.17%
3,251
– –
XOM icon
45
ExxonMobil
XOM
$634B
$410K 0.17%
3,527
– –
SYK icon
46
Stryker
SYK
$130B
$388K 0.16%
1,084
– –
PG icon
47
Procter & Gamble
PG
$339B
$307K 0.12%
1,891
– –
JPM icon
48
JPMorgan Chase
JPM
$950B
$300K 0.12%
1,500
– –
SLB icon
49
SLB Ltd
SLB
$75B
$299K 0.12%
5,450
– –
ABT icon
50
Abbott
ABT
$187B
$292K 0.12%
2,568
– –
1
2
3

Similar funds

PIA
PineBridge Investments Asia Hong Kong $289M AUM
CCC
Cable Car Capital San Francisco, California $289M AUM 26.33% 1-Year Est. Return
GIM
Goodlander Investment Management Dallas, Texas $289M AUM 225.62% 1-Year Est. Return
PSA
Plum Street Advisors New Orleans, Louisiana $289M AUM 17.28% 1-Year Est. Return
SI
Saxon Interests Houston, Texas $290M AUM 19.97% 1-Year Est. Return
FFA
Fairfield Financial Advisors Wellesley, Massachusetts $290M AUM 15.81% 1-Year Est. Return
OCM
Orion Capital Management Coronado, California $290M AUM 17.97% 1-Year Est. Return
ODFS
O'Donnell Financial Services San Rafael, California $290M AUM 15.6% 1-Year Est. Return

Bourne Lent Asset Management's Q1 2024 Portfolio in Review

As of Q1 2024, Bourne Lent Asset Management held 64 positions worth $248M, up 0.64% from $246M the previous quarter. Its ten largest holdings account for 73% of the portfolio.

Bourne Lent Asset Management's Q1 2024 filing shows 4 new, 10 increased, 10 reduced and 1 closed positions. Its largest new stake was IBM: 1,150 shares worth $220K. The largest sale was Invitae Corporation, an estimated $360K.

By sector, the portfolio is most concentrated in Technology at 45% of assets, down from 46% a quarter earlier, followed by Healthcare and Communication Services.

  • Bourne Lent Asset Management's largest Q1 2024 buy was IBM: 1,150 shares worth $220K.
  • Bourne Lent Asset Management added most to Pacific Biosciences in Q1 2024, an estimated $364K increase.
  • Bourne Lent Asset Management's biggest Q1 2024 reduction was Bristol-Myers Squibb, cutting an estimated $291K.
  • Bourne Lent Asset Management fully exited Invitae Corporation in Q1 2024, selling an estimated $360K.
  • Bourne Lent Asset Management's ten largest holdings make up 73% of its $248M portfolio in Q1 2024.
  • Bourne Lent Asset Management opened 4 new positions and closed 1 in Q1 2024.
  • Bourne Lent Asset Management's portfolio value rose 0.64% quarter-over-quarter to $248M.

Based on Bourne Lent Asset Management's 13F filing for Q1 2024, filed 12 Apr 2024.